Pfizer Czech Republic made a net profit of CZK 103 mil with revenues of CZK 3,586 mil in 2017, up by 39.7% and up by 10.6%, respectively, compared to the previous year. This translates into a net margin of 2.86%.
Historically, between 2002 - 2017, the firm’s net profit reached a high of CZK 272 mil in 2008 and a low of CZK -263 mil in 2002. Since 2012, the firm's net profit has increased 113% or 16.4% a year on average.
On the operating level, EBITDA reached CZK 156 mil, up 30.7% compared to the previous year. Over the last five years, company's EBITDA has risen 18.7% a year on average.
You can see all the company’s data at Pfizer Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
